Psychedelics for Medicinal Use: How Will This Alter the Collective Laboratory Consciousness?

导出原文传递

翻译打印收藏纠错

作者： Steven W,Cotten ^[1] ; Frederick G,Strathmann ^[2] ; Frederick S,Barrett ^[3] ; Laura,Labay ^[4] ; James,Mullally ^[5] ; Alexander M,Sherwood ^[6] ; Frank,Wiegand ^[7]

作者单位： Associate Professor, Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States. ^[1] Senior Vice President, Applied and Clinical Business Segments, MOBILion Systems, Chadds Ford, PA, United States. ^[2] Associate Director, Center for Psychedelic and Consciousness Research, Associate Professor, Psychiatry and Behavioral Sciences, The Johns Hopkins University School of Medicine, Baltimore, MD, United States. ^[3] Director, Toxicological Services, NMS Labs, Horsham, PA, United States. ^[4] Vice President, In Vitro Diagnostic Regulatory Affairs, MCRA, LLC, Washington, DC, United States. ^[5] Medicinal Chemist, Usona Institute, Fitchburg, WI, United States. ^[6] Chief Medical Officer, Beckley Psytech Ltd, San Francisco, CA, United States. ^[7]

主题词人类(Humans);致幻药(Hallucinogens);意识(Consciousness);脑(Brain)

DOI 10.1093/clinchem/hvad016

PMID 36881769

发布时间 2023-05-07

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交